icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
AASLD 2025
Washington, D.C.
November 7-11, 2025
 Back grey_arrow_rt.gif
 
 
 
Bepirovirsen B-Well Phase 3 trials: Predicting functional cure rates based upon hepatitis B surface antigen at Week 12
 
 
  AASLD 2026 Denver
 

1107261copy

1107262copy

1107263copy

1107264copy

1107265copy

1107266copy

1107267copy

1107268copy

1107269copy